19-5905080-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001017921.4(VMAC):c.190C>T(p.Arg64Cys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000272 in 1,351,726 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001017921.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VMAC | NM_001017921.4 | c.190C>T | p.Arg64Cys | missense_variant, splice_region_variant | 1/2 | ENST00000339485.4 | NP_001017921.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VMAC | ENST00000339485.4 | c.190C>T | p.Arg64Cys | missense_variant, splice_region_variant | 1/2 | 1 | NM_001017921.4 | ENSP00000343348 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000452 AC: 1AN: 2212Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 1344
GnomAD4 exome AF: 0.000282 AC: 338AN: 1199544Hom.: 0 Cov.: 31 AF XY: 0.000277 AC XY: 161AN XY: 580482
GnomAD4 genome AF: 0.000191 AC: 29AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 12, 2024 | The c.190C>T (p.R64C) alteration is located in exon 1 (coding exon 1) of the VMAC gene. This alteration results from a C to T substitution at nucleotide position 190, causing the arginine (R) at amino acid position 64 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at